Protocol deviation [Study Per­for­mance]

posted by Dr_Dan  – Germany, 2013-04-29 18:54 (4801 d 16:41 ago) – Posting: # 10506
Views: 8,232

Hi Helmut
You are thinking of a cross over design (within subject comparison), but what would you do in case of a parallel design study? Then it could make sense to perform the BE assessment excluding these subjects....
However, I agree that these deviations increase doubts on the CRO's procedures not complying with the protocol. They should be prepared for an inspection if this is a pivotal study to be submitted to regulatory authorities.
Kind regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
134 visitors (0 registered, 134 guests [including 21 identified bots]).
Forum time: 11:35 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5